These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3946461)

  • 41. [Study of the prevalence of hypercholesterolemia in Extremadura].
    Gimeno Ortiz A; Jiménez Romano R; Vázquez Domínguez JA; Rueda Muñoz C
    Rev Sanid Hig Publica (Madr); 1993; 67(4):267-78. PubMed ID: 7732293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The management of hypercholesterolemia revisited.
    Wiggins BS
    Manag Care Interface; 2001 Jan; 14(1):58-66, 72. PubMed ID: 11214536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
    Peters TK
    Am J Cardiol; 1995 Jul; 76(2):71A-75A. PubMed ID: 7604803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cholesterol-lowering treatment on coronary heart disease morbidity and mortality: the evidence from trials, and beyond.
    Katan MB
    Cardiology; 1990; 77 Suppl 4():8-13. PubMed ID: 2073675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesterol and cardiovascular disease: how strong is the evidence?
    LaRosa JC
    Clin Cardiol; 1992 Nov; 15(11):III2-7; discussion III8-9. PubMed ID: 1458693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cigarette smoking, adiposity, non-insulin-dependent diabetes, and coronary heart disease in Japanese-American men.
    Fujimoto WY; Leonetti DL; Bergstrom RW; Shuman WP; Wahl PW
    Am J Med; 1990 Dec; 89(6):761-71. PubMed ID: 1979206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LDL-cholesterol as a determinant of coronary heart disease.
    Hunninghake D
    Clin Ther; 1990; 12(5):370-5; discussion 369. PubMed ID: 2268861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL; Lenz ML; Taylor AA
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing perspectives in the prevention of coronary artery disease.
    Levy RI
    Am J Cardiol; 1986 May; 57(14):17G-26G. PubMed ID: 3087152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of coronary heart disease--propaganda, promises, problems, and prospects.
    Oliver MF
    Circulation; 1986 Jan; 73(1):1-9. PubMed ID: 3510083
    [No Abstract]   [Full Text] [Related]  

  • 53. Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine.
    Oster G; Epstein AM
    JAMA; 1987 Nov; 258(17):2381-7. PubMed ID: 3118060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed.
    Prasad K
    Atherosclerosis; 2005 Apr; 179(2):269-75. PubMed ID: 15777541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 57. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study.
    Castelli WP; Anderson K
    Am J Med; 1986 Feb; 80(2A):23-32. PubMed ID: 3946458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why are death rates from coronary heart disease decreasing? Which preventive measures are effective?
    Watkins LO
    Postgrad Med; 1984 Jun; 75(8):201-8, 211, 214. PubMed ID: 6610175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smoking, physical activity, and other predictors of endurance and heart rate response to exercise in asymptomatic hypercholesterolemic men. The Lipid Research Clinics Coronary Primary Prevention Trial.
    Gordon DJ; Leon AS; Ekelund LG; Sopko G; Probstfield JL; Rubenstein C; Sheffield LT
    Am J Epidemiol; 1987 Apr; 125(4):587-600. PubMed ID: 3826039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.